Cyxone’s Annual General Meeting moved to June 5, 2018
Cyxone announced today that the date of the company's Annual General Meeting (AGM) will be changed to June 5, 2018 due to the intensification of the work related to the financing of the company's drug candidate Rabeximod.The shareholders of Cyxone AB (publ) are hereby informed that the company's Annual General Meeting (AGM) will be postponed and held on Tuesday, June 5, 2018. It was previously scheduled for May 23, 2018. The reason for the time shift is derived from the in-depth work related to the financing of the company's drug candidate Rabeximod, which was acquired in 2017. Cyxone